Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

26 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CAR T cells in solid tumors: challenges and opportunities.
Marofi F, Motavalli R, Safonov VA, Thangavelu L, Yumashev AV, Alexander M, Shomali N, Chartrand MS, Pathak Y, Jarahian M, Izadi S, Hassanzadeh A, Shirafkan N, Tahmasebi S, Khiavi FM. Marofi F, et al. Among authors: chartrand ms. Stem Cell Res Ther. 2021 Jan 25;12(1):81. doi: 10.1186/s13287-020-02128-1. Stem Cell Res Ther. 2021. PMID: 33494834 Free PMC article. Review.
Mesenchymal stem/stromal cells as a valuable source for the treatment of immune-mediated disorders.
Markov A, Thangavelu L, Aravindhan S, Zekiy AO, Jarahian M, Chartrand MS, Pathak Y, Marofi F, Shamlou S, Hassanzadeh A. Markov A, et al. Among authors: chartrand ms. Stem Cell Res Ther. 2021 Mar 18;12(1):192. doi: 10.1186/s13287-021-02265-1. Stem Cell Res Ther. 2021. Retraction in: Stem Cell Res Ther. 2024 Apr 22;15(1):110. doi: 10.1186/s13287-024-03733-0 PMID: 33736695 Free PMC article. Retracted. Review.
Renaissance of armored immune effector cells, CAR-NK cells, brings the higher hope for successful cancer therapy.
Marofi F, Rahman HS, Thangavelu L, Dorofeev A, Bayas-Morejón F, Shirafkan N, Shomali N, Chartrand MS, Jarahian M, Vahedi G, Mohammed RN, Shahrokh S, Akbari M, Khiavi FM. Marofi F, et al. Among authors: chartrand ms. Stem Cell Res Ther. 2021 Mar 22;12(1):200. doi: 10.1186/s13287-021-02251-7. Stem Cell Res Ther. 2021. PMID: 33752707 Free PMC article. Review.
Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
Marofi F, Tahmasebi S, Rahman HS, Kaigorodov D, Markov A, Yumashev AV, Shomali N, Chartrand MS, Pathak Y, Mohammed RN, Jarahian M, Motavalli R, Motavalli Khiavi F. Marofi F, et al. Among authors: chartrand ms. Stem Cell Res Ther. 2021 Mar 29;12(1):217. doi: 10.1186/s13287-021-02283-z. Stem Cell Res Ther. 2021. PMID: 33781320 Free PMC article. Review.
Mesenchymal stem/stromal cell-derived exosomes in regenerative medicine and cancer; overview of development, challenges, and opportunities.
Hassanzadeh A, Rahman HS, Markov A, Endjun JJ, Zekiy AO, Chartrand MS, Beheshtkhoo N, Kouhbanani MAJ, Marofi F, Nikoo M, Jarahian M. Hassanzadeh A, et al. Among authors: chartrand ms. Stem Cell Res Ther. 2021 May 21;12(1):297. doi: 10.1186/s13287-021-02378-7. Stem Cell Res Ther. 2021. PMID: 34020704 Free PMC article. Review.
CAR-NK cell in cancer immunotherapy; A promising frontier.
Marofi F, Abdul-Rasheed OF, Rahman HS, Budi HS, Jalil AT, Yumashev AV, Hassanzadeh A, Yazdanifar M, Motavalli R, Chartrand MS, Ahmadi M, Cid-Arreguid A, Jarahian M. Marofi F, et al. Among authors: chartrand ms. Cancer Sci. 2021 Sep;112(9):3427-3436. doi: 10.1111/cas.14993. Epub 2021 Jul 7. Cancer Sci. 2021. PMID: 34050690 Free PMC article. Review.
Mesenchymal Stem/Stromal Cell-Based Delivery: A Rapidly Evolving Strategy for Cancer Therapy.
Hassanzadeh A, Altajer AH, Rahman HS, Saleh MM, Bokov DO, Abdelbasset WK, Marofi F, Zamani M, Yaghoubi Y, Yazdanifar M, Pathak Y, Chartrand MS, Jarahian M. Hassanzadeh A, et al. Among authors: chartrand ms. Front Cell Dev Biol. 2021 Jul 12;9:686453. doi: 10.3389/fcell.2021.686453. eCollection 2021. Front Cell Dev Biol. 2021. Retraction in: Front Cell Dev Biol. 2023 Sep 04;11:1285267. doi: 10.3389/fcell.2023.1285267 PMID: 34322483 Free PMC article. Retracted. Review.
Correction to: Any closer to successful therapy of multiple myeloma? CAR-T cell is a good reason for optimism.
Marofi F, Tahmasebi S, Rahman HS, Kaigorodov D, Markov A, Yumashev AV, Shomali N, Chartrand MS, Pathak Y, Mohammed RN, Jarahian M, Motavalli R, Khiavi FM. Marofi F, et al. Among authors: chartrand ms. Stem Cell Res Ther. 2021 Aug 6;12(1):443. doi: 10.1186/s13287-021-02523-2. Stem Cell Res Ther. 2021. PMID: 34362452 Free PMC article. No abstract available.
Novel CAR T therapy is a ray of hope in the treatment of seriously ill AML patients.
Marofi F, Rahman HS, Al-Obaidi ZMJ, Jalil AT, Abdelbasset WK, Suksatan W, Dorofeev AE, Shomali N, Chartrand MS, Pathak Y, Hassanzadeh A, Baradaran B, Ahmadi M, Saeedi H, Tahmasebi S, Jarahian M. Marofi F, et al. Among authors: chartrand ms. Stem Cell Res Ther. 2021 Aug 20;12(1):465. doi: 10.1186/s13287-021-02420-8. Stem Cell Res Ther. 2021. PMID: 34412685 Free PMC article. Review.
26 results